Emily focuses her practice on matters primarily for clients in the healthcare industry. She provides regulatory and compliance assistance on both a federal and state level. She has assisted clinical laboratories, hospitals, long-term acute care hospitals, community hospitals, physician specialty groups, telehealth providers, surgery centers, healthcare associations, pharmacies, and other healthcare providers on regulatory, licensing, compliance, reimbursement, contractual, and corporate matters. She has provided support to entities during licensure and accreditation surveys and assisted in navigating state professional licensure laws, CLIA standards and state and federal laboratory laws and regulations, government and private payor reimbursement, state and federal fraud and abuse rules, state telehealth laws, and state and federal pharmacy regulation. She also has advised clients on direct to consumer testing issues and applicable state requirements.
She also has experience with provider-based compliance issues and the 340B Federal Drug Pricing Program, including implementation, program compliance, audit preparation, and preparing for audits conducted by the Office of Pharmacy Affairs.
In addition, she has significant experience with HIPAA compliance, including drafting HIPAA policies and procedures, breach response and notification, drafting responses to investigations conducted by the Office for Civil Rights, and advising clients on proactive HIPAA compliance and breach prevention.
Prior to joining McDonald Hopkins, Emily served as healthcare attorney/senior consultant at a national legal-based healthcare management consulting firm and outside counsel to the National Association of Boards of Pharmacy.
Emily earned a J.D. from The John Marshall Law School in 2010. She received a B.A., Dean's List, from Illinois Wesleyan University in 2005.
Admissions - State
- The John Marshall Law School
- Illinois Wesleyan University
- Illinois State Bar Association
- Chicago Bar Association
March 1 deadline approaching to submit data breach reports
2018 maximum charges for copies of medical records in Illinois
OCR's HIPAA breach "wall of shame" breaks 2,000
FDA approves first digital pathology system for primary diagnosis
OCR issues guidance on cyber threat reporting and monitoring
2017 update on maximum charges for copies of medical records in Illinois
College of American Pathologists to develop Pathologist Quality Registry
FDA no longer releasing final guidance on laboratory developed tests
Phase 2 HIPAA audits are coming
OCR strikes again with 3 recent HIPAA settlements
Budget deal will impact hospital acquisitions of physician practices
OCR reminds business associates of HIPAA exposure
Guidance Recommends Health Care Cybersecurity Best Practices
EKRA expands federal Anti-Kickback Statute with new criminal penalties in health care industry
Act promptly to address HIPAA violations
UMass HIPAA settlement highlights importance of proper designation when electing hybrid status
HHS issues proposed omnibus 340b guidance
- "HIPAA: The Time for Compliance is Now," Northern Ohio Physician, Volume 101, No. 4, July/August 2016
- Eliminating Kickbacks in Recovery Act Webinar | Tuesday, August 20, 2019
- Eliminating Kickbacks in Recovery Act (EKRA) and the impact on the healthcare industry | Thursday, April 11, 2019
- How to Reduce Your Risk of HIPAA Rule Violations and Avoid Thousands in Fines and Penalties or Other Damaging Action by the OCR | Thursday, February 9, 2017
- Boot Camp: Building and Realizing Value in Your Dermatology Practice | Friday, November 4, 2016
External Speaking Engagements
- “Legal Landmines in Professional and Executive Employment: A Practical Discussion of Essential Contract Terms,” ASCP annual meeting, September 12, 2019
- “HIPAA Update for the Pathology Practice,” APF Annual Meeting, April 15, 2019